Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
Biomarin Pharmaceutical Inc (NASDAQ: BMRN) closed the day trading at $59.32 down -0.54% from the previous closing price of $59.64. In other words, the price has decreased by -$0.54 from its previous closing price. On the day, 1.3 million shares were traded.
Ratios:
For a better understanding of BMRN, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 8.94 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 18.23. For the most recent quarter (mrq), Quick Ratio is recorded 3.49 and its Current Ratio is at 5.52. In the meantime, Its Debt-to-Equity ratio is 0.11 whereas as Long-Term Debt/Eq ratio is at 0.10.
On November 15, 2024, Wolfe Research started tracking the stock assigning a Outperform rating and target price of $95.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on May 02 ’25 when Hubbard Cristin sold 273 shares for $64.92 per share. The transaction valued at 17,723 led to the insider holds 32,700 shares of the business.
Hubbard Cristin bought 273 shares of BMRN for $17,723 on May 02 ’25. On Mar 19 ’25, another insider, Burkhart Erin, who serves as the GVP, Chief Accounting Officer of the company, sold 1,295 shares for $71.52 each. As a result, the insider received 92,618 and left with 16,955 shares of the company.
Valuation Measures:
As of this moment, Biomarin’s Price-to-Earnings (P/E) ratio for their current fiscal year is 22.01, and their Forward P/E ratio for the next fiscal year is 13.61. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 0.67. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.89 while its Price-to-Book (P/B) ratio in mrq is 1.96.
Stock Price History:
Over the past 52 weeks, BMRN has reached a high of $94.85, while it has fallen to a 52-week low of $52.93. The 50-Day Moving Average of the stock is -10.09%, while the 200-Day Moving Average is calculated to be -15.86%.
Shares Statistics:
A total of 191.76M shares are outstanding, with a floating share count of 189.18M. Insiders hold about 1.36% of the company’s shares, while institutions hold 97.08% stake in the company.
